About Technology Issues FAQ

Links

A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study

A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.